dr. ledermann on the results of the ariel3 trial in ovarian cancer
Published 6 years ago • 62 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:19
dr. ledermann on phase iii ariel3 results in ovarian cancer
-
1:20
dr. ledermann on rationale for ariel3 trial in ovarian cancer
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
1:14
dr. ledermann on the treatment landscape for rare gynecologic cancers
-
0:58
dr. ledermann on systemic treatment for rare gynecologic tumors
-
1:42
dr. ledermann on rucaparib maintenance in ovarian cancer
-
6:12
rucaparib for recurrent ovarian cancer
-
1:14
dr. coleman on benefit of rucaparib in ovarian cancer
-
2:17
results of the velia trial in ovarian cancer
-
1:07
dr. petrylak on the results of the ev-103 trial in bladder cancer
-
1:57
dr. ledermann on parp inhibitors in maintenance therapy for ovarian cancer
-
1:56
dr. maurie markman on the phase iii aurelia trial for platinum-resistant ovarian cancer
-
2:32
dr. markman on the era of precision medicine in ovarian cancer
-
2:12
dr. patel on an analysis of olaparib and cediranib for ovarian cancer
-
1:53
dr. ulahannan on the prodige 35 trial in pancreatic cancer
-
1:18
dr. branagan on the results of the tourmaline-mm3 trial in multiple myeloma
-
8:07
highly anticipated data from the solo-1 trial
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer